An Investigational New Drug (IND) candidate developed by Xentria to suppress the physiologic response to tumor necrosis factor.
Sarcoidosis - A rare inflammatory disease that interferes with an organ’s structure and function.
Sarcoidosis is characterized by the formation of granulomas—tiny clumps of inflammatory cells—in one or more organs of the body.
Xentria is partnered with the Foundation for Sarcoidosis Research (FSR). Additional information for patients and caregivers looking to connect with others facing this disease can be found here.Visit FSR's Website